Inrig Jula bought TVTX
January 31, 2026 · Form 4 insider transaction
Inrig Jula bought 75,000 shares of Travere Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderInrig Jula
RoleOfficer
SecurityEmployee stock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 31, 2026
Filing dateFebruary 3, 2026
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.